In our note from the Editor in Chief, Dr. Feder underlines the hope for better outcomes for the ravages of substance use disorders and a timely message for those impacted wildfires and other disasters.

Second generation antipsychotics (SGAs) have significant side effects, which has led us at Carlat to recommend conservative use. This research update adds to concerns about increased mortality, especially at higher doses, making conservative use of SGAs a necessity.

Where does escitalopram fit in the treatment of anxiety, depression, OCD, and other disorders of children and adolescents? We review the data and help you decide where to place escitalopram in your own practice.

There are multiple ways that we can help our patients reduce the risk of overdose. In our interview with Dr. Aaron Quiggle, we cover screening, fentanyl testing, the use of Narcan and the importance of learning to prescribe buprenorphine.

One of the most challenging problems in adolescent care is figuring out what level of care will give patients the best chance of recovery or progress. We give you a guide to decide what level of care to recommend based on your individual patient.

Can kids and teens "catch" mental illness from the internet? This clinical update covers how to assess the degree of media influence on symptoms that children and adolescents report and how to talk with kids and teens about self-diagnoses in a way that builds a collaborative exploratory treatment relationship.

Online treatment offers greater access to care for our patients with reduced travel and environmental costs. But is this modality effective? This research update looks at a study in which internet-based cognitive behavioral therapy was used for treating OCD in children and teens.

What is the impact of alcohol use in teens on their risk for developing depression? Spoiler alert: If it were a clear linear relationship, there would be no story here. Read this research update and use it to improve your process for screening for alcohol use.